<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08595610403508</udiDi>
    <basicUdiDi>85956104VGHAYC</basicUdiDi>
    <tradeName>HYALOSAN vaginální gel s kyselinou hyaluronovou</tradeName>
    <deviceName>Vaginální gel s kyselinou hyaluronovou</deviceName>
    <manufacturerName>Dr. Müller Pharma s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000000005</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PC0251_001</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-07-03T14:03:50.743Z</lastUpdated>
  </row>
  <row>
    <udiDi>08595610406806</udiDi>
    <basicUdiDi>85956104VGHAYC</basicUdiDi>
    <tradeName>HYALOSAN vaginal gel with hyaluronic acid</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Dr. Müller Pharma s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000000005</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>PC0251_004</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-27T06:10:54.163Z</lastUpdated>
  </row>
</eudamedExport>